Document is current
Any future updates will be listed below
-
Authors
Marzhoseyni, Zeynab
Shojaie, Layla https://orcid.org/0000-0002-5020-5181
Tabatabaei, Seyed Alireza
Movahedpour, Ahmad
Safari, Mahmood
Esmaeili, Davoud
Mahjoubin-Tehran, Maryam https://orcid.org/0000-0001-5719-5345
Jalili, Amin
Morshedi, Korosh
Khan, Haroon
Okhravi, Ranaa
Hamblin, Michael R.
Mirzaei, Hamed https://orcid.org/0000-0002-9399-8281
- License Information
-
More Information
Article History
Received: 26 August 2020
Revised: 25 January 2021
Accepted: 5 February 2021
First Online: 22 March 2021
Compliance with ethical standards
:
: MRH declares the following potential conflicts of interest. Scientific Advisory Boards: Transdermal Cap Inc, Cleveland, OH; BeWell Global Inc, Wan Chai, Hong Kong; Hologenix Inc. Santa Monica, CA; LumiTheraInc, Poulsbo, WA; Vielight, Toronto, Canada; Bright Photomedicine, Sao Paulo, Brazil; Quantum Dynamics LLC, Cambridge, MA; Global Photon Inc, Bee Cave, TX; Medical Coherence, Boston MA; NeuroThera, Newark DE; JOOVV Inc, Minneapolis-St. Paul MN; AIRx Medical, Pleasanton CA; FIR Industries, Inc. Ramsey, NJ; UVLRx Therapeutics, Oldsmar, FL; Ultralux UV Inc, Lansing MI; Illumiheal&Petthera, Shoreline, WA; MB Lasertherapy, Houston, TX; ARRC LED, San Clemente, CA; Varuna Biomedical Corp. Incline Village, NV; Niraxx Light Therapeutics, Inc, Boston, MA. Consulting; Lexington Int, Boca Raton, FL; USHIO Corp, Japan; Merck KGaA, Darmstadt, Germany; Philips Electronics Nederland B.V. Eindhoven, Netherlands; Johnson & Johnson Inc, Philadelphia, PA; Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany. Stockholdings: Global Photon Inc, Bee Cave, TX; Mitonix, Newark, DE. The other authors declare no conflict of interest.
